Login to Your Account

Clinic Roundup

Monday, September 10, 2012
• Eaton Scientific Systems Ltd., of Beverly Hills, Calif., a wholly owned subsidiary of Pristine Solutions Inc., said it completed the protocol for the Phase I/II study of Tropine 3, its version of homatropine in oral suspension, for women afflicted with hot flashes during pre-menopause, perimenopause and postmenopause.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription